Sir Horace Smirk. Pioneer in drug treatment of hypertension.
Author:
Open Access
- 1 February 1991
- journal article
- other
- Published by Wolters Kluwer Health in Hypertension
- Vol. 17 (2) , 247-250
Abstract
Sir Horace Smirk deserves much of the credit for establishing the benefits of reducing blood pressure. He was one of the main early proponents of the idea that it was the raised intra-arterial pressure itself that caused many of the cardiac and vascular complications of hypertension. His training in both pharmacology and internal medicine enabled him to devise practical methods for successful treatment of hypertension with ganglion blocking drugs such as hexamethonium. The major clinical benefits that followed such drug treatment proved a great stimulus to the development of drugs with fewer disadvantages and to widespread acceptance of the beneficial effects of antihypertensive drug treatment.Keywords
This publication has 23 references indexed in Scilit:
- A myocardial syndromeThe American Journal of Cardiology, 1960
- CONTROL OF BLOOD-PRESSURE BY COMBINED ACTION OF RESERPINE AND PENTAPYRROLIDINIUMThe Lancet, 1954
- Clinical Evaluation of 1-Hydrazinophthalazin (C-5968) in HypertensionCirculation, 1952
- Treatment of Severe Hypertension with Hexamethonium BromideBMJ, 1950
- "MEDICAL SYMPATHECTOMY" IN HYPERTENSION A CLINICAL STUDY OF METHONIUM COMPOUNDSThe Lancet, 1950
- PENTAMETHONIUM IN HYPERTENSIONThe Lancet, 1950
- Pentamethonium and Hexamethonium Iodide in Vascular Disease and HypertensionBMJ, 1950
- CASUAL AND BASAL BLOOD PRESSURES IV. THEIR RELATIONSHIP TO THE SUPPLEMENTAL PRESSURE WITH A NOTE ON STATISTICAL IMPLICATIONSHeart, 1944
- CASUAL AND BASAL BLOOD PRESSURES I. IN BRITISH AND EGYPTIAN MENHeart, 1943
- V.—On the Connection between Chemical Constitution and Physiological Action. Part. I.—On the Physiological Action of the Salts of the Ammonium Bases, derived from Strychnia, Brucia, Thebaia, Codeia, Morphia, and NicotiaTransactions of the Royal Society of Edinburgh, 1868